Meet our people

< see all people

Olivier Leclerc

Senior Partner

Olivier Leclerc is a Senior Partner in McKinsey’s Southern California office. He assists pharmaceutical, biotech, and medical products clients in capturing a range of strategic and operational improvement opportunities. He serves clients ranging from large biopharmaceutical companies to pre-IPO biotechnology start-ups, as well as investment and venture capital firms.

His expertise covers the entire biopharma value chain from discovery to commercialization and market access. He has conducted multiple engagements on portfolio prioritization and technology assessments in biotechnology and specialty pharmaceuticals.

He has supported various product launch efforts across multiple therapeutic areas ranging from oncology to digestive health and medical nutrition. He collaborates with client executives to optimize commercialization and go-to-market approaches, contributing to product positioning, fulfillment, and pricing/contracting strategies.

In addition to working directly with executives at products companies, Olivier has contributed to multiple due diligence engagements for private-equity funds that are considering investments in healthcare payers, providers, or services firms. He works extensively with venture capital firms and their portfolio companies in biotechnology.

Olivier also leads McKinsey's Digital service line for our Global Pharmaceutical and Medical Product Practice, and co-leads our Oncology service line. Prior to joining McKinsey, Olivier worked for 2 global consumer goods companies in Hong Kong and China in sales and marketing roles.

Olivier received an MBA from Harvard University, a BA in business & economics from Hautes Etudes Commerciales (HEC), Jouy-en-Josas, France, and a JD (equivalent) in French corporate and tax law from University of Paris, France. Recent articles of Olivier’s include “How to succeed as a chief digital officer in pharma” (McKinsey & Company, March 2017), “How pharma can win in a digital world” (McKinsey & Company, December 2015), and “The road to digital success in pharma” (McKinsey & Company, August 2015).